Cargando…

Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system

BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruta, James K, Dayton, Paul A, Gallippi, Caterina M, O'Rand, Michael G, Streicker, Michael A, Gessner, Ryan C, Gregory, Thomas S, Silva, Erick JR, Hamil, Katherine G, Moser, Glenda J, Sokal, David C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340307/
https://www.ncbi.nlm.nih.gov/pubmed/22289508
http://dx.doi.org/10.1186/1477-7827-10-7
_version_ 1782231444164182016
author Tsuruta, James K
Dayton, Paul A
Gallippi, Caterina M
O'Rand, Michael G
Streicker, Michael A
Gessner, Ryan C
Gregory, Thomas S
Silva, Erick JR
Hamil, Katherine G
Moser, Glenda J
Sokal, David C
author_facet Tsuruta, James K
Dayton, Paul A
Gallippi, Caterina M
O'Rand, Michael G
Streicker, Michael A
Gessner, Ryan C
Gregory, Thomas S
Silva, Erick JR
Hamil, Katherine G
Moser, Glenda J
Sokal, David C
author_sort Tsuruta, James K
collection PubMed
description BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer could be used as the basis for a male contraceptive. METHODS: Sprague-Dawley rats were anesthetized and their testes were treated with 1 MHz or 3 MHz ultrasound while varying power, duration and temperature of treatment. RESULTS: We found that 3 MHz ultrasound delivered with 2.2 Watt per square cm power for fifteen minutes was necessary to deplete spermatocytes and spermatids from the testis and that this treatment significantly reduced epididymal sperm reserves. 3 MHz ultrasound treatment reduced total epididymal sperm count 10-fold lower than the wet-heat control and decreased motile sperm counts 1,000-fold lower than wet-heat alone. The current treatment regimen provided nominally more energy to the treatment chamber than Fahim's originally reported conditions of 1 MHz ultrasound delivered at 1 Watt per square cm for ten minutes. However, the true spatial average intensity, effective radiating area and power output of the transducers used by Fahim were not reported, making a direct comparison impossible. We found that germ cell depletion was most uniform and effective when we rotated the therapeutic transducer to mitigate non-uniformity of the beam field. The lowest sperm count was achieved when the coupling medium (3% saline) was held at 37 degrees C and two consecutive 15-minute treatments of 3 MHz ultrasound at 2.2 Watt per square cm were separated by 2 days. CONCLUSIONS: The non-invasive nature of ultrasound and its efficacy in reducing sperm count make therapeutic ultrasound a promising candidate for a male contraceptive. However, further studies must be conducted to confirm its efficacy in providing a contraceptive effect, to test the result of repeated use, to verify that the contraceptive effect is reversible and to demonstrate that there are no detrimental, long-term effects from using ultrasound as a method of male contraception.
format Online
Article
Text
id pubmed-3340307
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33403072012-05-01 Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system Tsuruta, James K Dayton, Paul A Gallippi, Caterina M O'Rand, Michael G Streicker, Michael A Gessner, Ryan C Gregory, Thomas S Silva, Erick JR Hamil, Katherine G Moser, Glenda J Sokal, David C Reprod Biol Endocrinol Research BACKGROUND: Studies published in the 1970s by Mostafa S. Fahim and colleagues showed that a short treatment with ultrasound caused the depletion of germ cells and infertility. The goal of the current study was to determine if a commercially available therapeutic ultrasound generator and transducer could be used as the basis for a male contraceptive. METHODS: Sprague-Dawley rats were anesthetized and their testes were treated with 1 MHz or 3 MHz ultrasound while varying power, duration and temperature of treatment. RESULTS: We found that 3 MHz ultrasound delivered with 2.2 Watt per square cm power for fifteen minutes was necessary to deplete spermatocytes and spermatids from the testis and that this treatment significantly reduced epididymal sperm reserves. 3 MHz ultrasound treatment reduced total epididymal sperm count 10-fold lower than the wet-heat control and decreased motile sperm counts 1,000-fold lower than wet-heat alone. The current treatment regimen provided nominally more energy to the treatment chamber than Fahim's originally reported conditions of 1 MHz ultrasound delivered at 1 Watt per square cm for ten minutes. However, the true spatial average intensity, effective radiating area and power output of the transducers used by Fahim were not reported, making a direct comparison impossible. We found that germ cell depletion was most uniform and effective when we rotated the therapeutic transducer to mitigate non-uniformity of the beam field. The lowest sperm count was achieved when the coupling medium (3% saline) was held at 37 degrees C and two consecutive 15-minute treatments of 3 MHz ultrasound at 2.2 Watt per square cm were separated by 2 days. CONCLUSIONS: The non-invasive nature of ultrasound and its efficacy in reducing sperm count make therapeutic ultrasound a promising candidate for a male contraceptive. However, further studies must be conducted to confirm its efficacy in providing a contraceptive effect, to test the result of repeated use, to verify that the contraceptive effect is reversible and to demonstrate that there are no detrimental, long-term effects from using ultrasound as a method of male contraception. BioMed Central 2012-01-30 /pmc/articles/PMC3340307/ /pubmed/22289508 http://dx.doi.org/10.1186/1477-7827-10-7 Text en Copyright ©2012 Tsuruta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tsuruta, James K
Dayton, Paul A
Gallippi, Caterina M
O'Rand, Michael G
Streicker, Michael A
Gessner, Ryan C
Gregory, Thomas S
Silva, Erick JR
Hamil, Katherine G
Moser, Glenda J
Sokal, David C
Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title_full Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title_fullStr Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title_full_unstemmed Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title_short Therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
title_sort therapeutic ultrasound as a potential male contraceptive: power, frequency and temperature required to deplete rat testes of meiotic cells and epididymides of sperm determined using a commercially available system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340307/
https://www.ncbi.nlm.nih.gov/pubmed/22289508
http://dx.doi.org/10.1186/1477-7827-10-7
work_keys_str_mv AT tsurutajamesk therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT daytonpaula therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT gallippicaterinam therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT orandmichaelg therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT streickermichaela therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT gessnerryanc therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT gregorythomass therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT silvaerickjr therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT hamilkatherineg therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT moserglendaj therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem
AT sokaldavidc therapeuticultrasoundasapotentialmalecontraceptivepowerfrequencyandtemperaturerequiredtodepleterattestesofmeioticcellsandepididymidesofspermdeterminedusingacommerciallyavailablesystem